Efficacy of Prostatic Artery Embolization for Catheter-Dependent Patients with Large Prostate Sizes and High Comorbidity Scores

Shivank Bhatia, Vishal K. Sinha, Bruce Kava, Christopher Gomez, Sardis Harward, Sanoj Punnen, Mohamed Kably, Jeffrey Miller, Dipen J Parekh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose To evaluate efficacy and safety of prostate artery embolization (PAE) in urinary catheter–dependent patients with large prostate volumes and high comorbidity scores. Materials and Methods A retrospective single-center review was conducted of 30 patients with urinary retention at time of PAE from November 2014 through February 2017. Mean (range) age was 73.1 years (48–94 y), age-adjusted Charlson comorbidity index was 4.5 (0–10), duration of urinary retention was 63.4 days (2–224 d), International Prostate Symptom Score quality-of-life (IPSS-QOL) was 5.3 (3–6), and prostate volume was 167.3 cm3 (55–557 cm3). These parameters were collected at 3, 6, and 12 months after PAE. Trials of voiding were performed approximately 2 weeks after PAE and, if failed, every 2 weeks thereafter. Adverse events were graded using the Clavien-Dindo classification. Results At a mean (range) of 18.2 days (1–72 d), 26 (86.7%) patients were no longer reliant on catheters. Follow-up was obtained in all patients eligible at 3 and 6 months and 17 of 20 (85.0%) patients eligible at 1 year. Mean (range) IPSS-QOL improved significantly to 1.2 (0–5), 0.7 (0–4), and 0.6 (0–4) at 3, 6, and 12 months (all P <.001). Mean (range) prostate volume decreased significantly to 115.9 cm3 (27–248 cm3) at 3 months (P <.001). Two patients experienced grade II urosepsis complications, which were successfully treated with intravenous antibiotics. All other complications were self-limited grade I complications. Conclusions PAE represents a safe and effective option for management of patients with urinary retention, especially patients with large prostates who are not ideal surgical candidates.

Original languageEnglish (US)
Pages (from-to)78-84.e1
JournalJournal of Vascular and Interventional Radiology
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Comorbidity
Prostate
Catheters
Arteries
Urinary Retention
Quality of Life
Anti-Bacterial Agents
Safety

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Efficacy of Prostatic Artery Embolization for Catheter-Dependent Patients with Large Prostate Sizes and High Comorbidity Scores. / Bhatia, Shivank; Sinha, Vishal K.; Kava, Bruce; Gomez, Christopher; Harward, Sardis; Punnen, Sanoj; Kably, Mohamed; Miller, Jeffrey; Parekh, Dipen J.

In: Journal of Vascular and Interventional Radiology, Vol. 29, No. 1, 01.01.2018, p. 78-84.e1.

Research output: Contribution to journalArticle

@article{12b4da5e820e42178dcf00ea2c1161fa,
title = "Efficacy of Prostatic Artery Embolization for Catheter-Dependent Patients with Large Prostate Sizes and High Comorbidity Scores",
abstract = "Purpose To evaluate efficacy and safety of prostate artery embolization (PAE) in urinary catheter–dependent patients with large prostate volumes and high comorbidity scores. Materials and Methods A retrospective single-center review was conducted of 30 patients with urinary retention at time of PAE from November 2014 through February 2017. Mean (range) age was 73.1 years (48–94 y), age-adjusted Charlson comorbidity index was 4.5 (0–10), duration of urinary retention was 63.4 days (2–224 d), International Prostate Symptom Score quality-of-life (IPSS-QOL) was 5.3 (3–6), and prostate volume was 167.3 cm3 (55–557 cm3). These parameters were collected at 3, 6, and 12 months after PAE. Trials of voiding were performed approximately 2 weeks after PAE and, if failed, every 2 weeks thereafter. Adverse events were graded using the Clavien-Dindo classification. Results At a mean (range) of 18.2 days (1–72 d), 26 (86.7{\%}) patients were no longer reliant on catheters. Follow-up was obtained in all patients eligible at 3 and 6 months and 17 of 20 (85.0{\%}) patients eligible at 1 year. Mean (range) IPSS-QOL improved significantly to 1.2 (0–5), 0.7 (0–4), and 0.6 (0–4) at 3, 6, and 12 months (all P <.001). Mean (range) prostate volume decreased significantly to 115.9 cm3 (27–248 cm3) at 3 months (P <.001). Two patients experienced grade II urosepsis complications, which were successfully treated with intravenous antibiotics. All other complications were self-limited grade I complications. Conclusions PAE represents a safe and effective option for management of patients with urinary retention, especially patients with large prostates who are not ideal surgical candidates.",
author = "Shivank Bhatia and Sinha, {Vishal K.} and Bruce Kava and Christopher Gomez and Sardis Harward and Sanoj Punnen and Mohamed Kably and Jeffrey Miller and Parekh, {Dipen J}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jvir.2017.08.022",
language = "English (US)",
volume = "29",
pages = "78--84.e1",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Efficacy of Prostatic Artery Embolization for Catheter-Dependent Patients with Large Prostate Sizes and High Comorbidity Scores

AU - Bhatia, Shivank

AU - Sinha, Vishal K.

AU - Kava, Bruce

AU - Gomez, Christopher

AU - Harward, Sardis

AU - Punnen, Sanoj

AU - Kably, Mohamed

AU - Miller, Jeffrey

AU - Parekh, Dipen J

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose To evaluate efficacy and safety of prostate artery embolization (PAE) in urinary catheter–dependent patients with large prostate volumes and high comorbidity scores. Materials and Methods A retrospective single-center review was conducted of 30 patients with urinary retention at time of PAE from November 2014 through February 2017. Mean (range) age was 73.1 years (48–94 y), age-adjusted Charlson comorbidity index was 4.5 (0–10), duration of urinary retention was 63.4 days (2–224 d), International Prostate Symptom Score quality-of-life (IPSS-QOL) was 5.3 (3–6), and prostate volume was 167.3 cm3 (55–557 cm3). These parameters were collected at 3, 6, and 12 months after PAE. Trials of voiding were performed approximately 2 weeks after PAE and, if failed, every 2 weeks thereafter. Adverse events were graded using the Clavien-Dindo classification. Results At a mean (range) of 18.2 days (1–72 d), 26 (86.7%) patients were no longer reliant on catheters. Follow-up was obtained in all patients eligible at 3 and 6 months and 17 of 20 (85.0%) patients eligible at 1 year. Mean (range) IPSS-QOL improved significantly to 1.2 (0–5), 0.7 (0–4), and 0.6 (0–4) at 3, 6, and 12 months (all P <.001). Mean (range) prostate volume decreased significantly to 115.9 cm3 (27–248 cm3) at 3 months (P <.001). Two patients experienced grade II urosepsis complications, which were successfully treated with intravenous antibiotics. All other complications were self-limited grade I complications. Conclusions PAE represents a safe and effective option for management of patients with urinary retention, especially patients with large prostates who are not ideal surgical candidates.

AB - Purpose To evaluate efficacy and safety of prostate artery embolization (PAE) in urinary catheter–dependent patients with large prostate volumes and high comorbidity scores. Materials and Methods A retrospective single-center review was conducted of 30 patients with urinary retention at time of PAE from November 2014 through February 2017. Mean (range) age was 73.1 years (48–94 y), age-adjusted Charlson comorbidity index was 4.5 (0–10), duration of urinary retention was 63.4 days (2–224 d), International Prostate Symptom Score quality-of-life (IPSS-QOL) was 5.3 (3–6), and prostate volume was 167.3 cm3 (55–557 cm3). These parameters were collected at 3, 6, and 12 months after PAE. Trials of voiding were performed approximately 2 weeks after PAE and, if failed, every 2 weeks thereafter. Adverse events were graded using the Clavien-Dindo classification. Results At a mean (range) of 18.2 days (1–72 d), 26 (86.7%) patients were no longer reliant on catheters. Follow-up was obtained in all patients eligible at 3 and 6 months and 17 of 20 (85.0%) patients eligible at 1 year. Mean (range) IPSS-QOL improved significantly to 1.2 (0–5), 0.7 (0–4), and 0.6 (0–4) at 3, 6, and 12 months (all P <.001). Mean (range) prostate volume decreased significantly to 115.9 cm3 (27–248 cm3) at 3 months (P <.001). Two patients experienced grade II urosepsis complications, which were successfully treated with intravenous antibiotics. All other complications were self-limited grade I complications. Conclusions PAE represents a safe and effective option for management of patients with urinary retention, especially patients with large prostates who are not ideal surgical candidates.

UR - http://www.scopus.com/inward/record.url?scp=85033771062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033771062&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2017.08.022

DO - 10.1016/j.jvir.2017.08.022

M3 - Article

C2 - 29150394

AN - SCOPUS:85033771062

VL - 29

SP - 78-84.e1

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 1

ER -